Baxter International Inc.

Symbol: BAX     Sector: Healthcare     Industry: Medical Instruments & Equipment

Dividend Yield
1.07%
Current Price
$82.43
Info     Dividend Rate History     Earnings     Financials     Rankings

Financials 2019

Update: 2019-06-09 11:40:01

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 1

2019-03-31
2,525,000,000
2,632,000,000
1,552,000,000
1,080,000,000
696,000,000
384,000,000
347,000,000
-
-
n.a.
-
-
-
-
-
-
-
 
129,000,000

Financials 2018

Update: 2019-06-09 11:40:01

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 4

2018-12-31
2,719,000,000
2,841,000,000
1,649,000,000
1,192,000,000
714,000,000
478,000,000
348,000,000
5,919,000,000
15,641,000,000
7,825,000,000
7,794,000,000
1,832,000,000
4,000,000
1,832,000,000
3,477,000,000
-976,000,000
755,000,000
 
175,000,000

Q 3

2018-09-30
2,621,000,000
2,767,000,000
1,531,000,000
1,236,000,000
851,000,000
385,000,000
544,000,000
7,028,000,000
16,847,000,000
7,734,000,000
9,130,000,000
2,860,000,000
3,000,000
2,860,000,000
3,488,000,000
26,000,000
489,000,000
 
166,000,000

Q 2

2018-06-30
2,703,000,000
2,842,000,000
1,603,000,000
1,239,000,000
855,000,000
384,000,000
343,000,000
6,890,000,000
16,578,000,000
7,709,000,000
8,881,000,000
2,857,000,000
3,000,000
2,857,000,000
3,498,000,000
-23,000,000
405,000,000
 
174,000,000

Q 1

2018-03-31
2,574,000,000
2,677,000,000
1,563,000,000
1,114,000,000
762,000,000
352,000,000
389,000,000
6,956,000,000
16,890,000,000
7,797,000,000
9,099,000,000
2,947,000,000
3,000,000
2,947,000,000
3,553,000,000
-472,000,000
447,000,000
 
140,000,000

Financials 2017

Update: 2019-06-09 11:40:01

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 4

2017-12-31
2,664,000,000
2,774,000,000
1,618,000,000
1,156,000,000
898,000,000
258,000,000
-71,000,000
7,263,000,000
17,111,000,000
7,995,000,000
9,124,000,000
3,394,000,000
3,000,000
3,394,000,000
3,512,000,000
-38,000,000
514,000,000
 
185,000,000